欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/4927/001
药品名称Pemetrexed Sandoz 25 mg/ml, concentrate for solution for infusion
活性成分
    • Pemetrexed disodium 25.0 mg/ml
剂型Concentrate for solution for infusion
上市许可持有人Sandoz B.V. Veluwezoom 22 1327 AH Almere The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Pemetrexed Sandoz 25 mg/ml, concentraat voor oplossing voor infusie
互认成员国 - 产品名称
    • Denmark (DK)
      Pemtrexed "Hexal"
    • Belgium (BE)
      Pemetrexed Sandoz 25 mg/ml concentraat voor oplossing voor infusie
    • Iceland (IS)
      Pemetrexed Hexal 25 mg/ml Innrennslisþykkni, lausn
    • Austria (AT)
      Pemetrexed Sandoz 25 mg/ml – Konzentrat zur Herstellung einer Infusionslösung
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
      Pemetrexed Hexal
    • Finland (FI)
    • Poland (PL)
      Pemetrexed Sandoz
    • Lithuania (LT)
      Pemetrexed Ebewe 25 mg/ml koncentratas infuziniam tirpalui
    • Bulgaria (BG)
      Pemetrexed Sandoz
    • Romania (RO)
    • Slovenia (SI)
    • Cyprus (CY)
      Pemetrexed Sandoz πυκνό διάλυμα για παρασκευή διαλύματος προς έγχυση 25mg/ml
    • Malta (MT)
    • Croatia (HR)
    • United Kingdom (Northern Ireland) (XI)
许可日期2020/06/10
最近更新日期2025/01/16
药物ATC编码
    • L01BA04 pemetrexed
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase